Duopharma Biotech Berhad (KLSE:DPHARMA)

Malaysia flag Malaysia · Delayed Price · Currency is MYR
1.300
-0.020 (-1.52%)
At close: Oct 1, 2025
-1.52%
Market Cap1.26B
Revenue (ttm)886.92M
Net Income (ttm)76.52M
Shares Out961.94M
EPS (ttm)0.08
PE Ratio16.46
Forward PE13.48
Dividend0.03 (2.31%)
Ex-Dividend DateSep 8, 2025
Volume762,900
Average Volume584,445
Open1.320
Previous Close1.320
Day's Range1.290 - 1.320
52-Week Range1.070 - 1.460
Beta0.36
RSI37.33
Earnings DateNov 7, 2025

About Duopharma Biotech Berhad

Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products, such as vitamins, minerals, and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others. It also provides sp... [Read more]

Industry Pharmaceutical Preparations
Founded 1978
Employees 1,957
Stock Exchange Bursa Malaysia
Ticker Symbol DPHARMA
Full Company Profile

Financial Performance

In 2024, Duopharma Biotech Berhad's revenue was 813.70 million, an increase of 15.46% compared to the previous year's 704.73 million. Earnings were 62.65 million, an increase of 19.00%.

Financial Statements

News

There is no news available yet.